Starting in 2007, a study in 227 adult CKD patients found a significant association between circulating concentrations of biologically active intact FGF23 with estimated GFR (eGFR) across all stages of renal dysfunction at baseline [12]. Here, FGF23 is linked to chronic kidney disease.